Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Healthcare, Regulatory and Reimbursement Landscape BrazilLarge Working Age Population gives Brazil the Edge in Terms of Human Resource Potential
By: Rajesh Gunnam The pharmaceutical market in Brazil was estimated at $19 billion in 2010, having increased from $9 billion in 2005 at a Compound Annual Growth Rate (CAGR) of 21%. It is expected to reach $55 billion by 2020. Brazil is one of the fastest growing pharmaceutical markets in the world. Approximately 24% of the market comprises generic drugs. Government regulations and initiatives have supported the domestic pharmaceutical industry’s generic development, and growth is expected to remain high due to the expiry of several blockbuster drugs in the near future and government’s emphasis on increasing the use of generics. The medical device market in Brazil was estimated at $7 billion in 2010. It ranks among the top 10 markets in the world and is the largest in South America. It is projected to reach $14 billion by 2020 at a CAGR of 6.8% from 2011. In 2010, the main segments of the medical devices market were ophthalmic devices ($1.4 billion), in vitro diagnostics devices ($810m) and diagnostic imaging devices ($697m). For Sample Pages, please click or add the below link to your browser: http://www.globaldata.com/ The medical device market in Brazil is expected to grow significantly in the future due to the increasingly elderly population, insurance coverage, advances in medical technology, and increasing awareness of and emphasis on early diagnosis. The key segments expected to show high growth in the future include cardiology, ophthalmology, rehabilitation, and plastic surgery. Approximately 50% of demand for medical equipment in Brazil is met through imports. The largest share of the import market is held by the US, although European and Japanese suppliers are also considered to have a good reputation. A significant reduction in trade barriers such as tariffs and import licensing has resulted in high growth in the medical equipment sector. Brazil’s hospital system comprises a significant part of both the public and private sector. For activities classified under the Unified Health System (Sistema Único de Saúde, SUS) plan, private hospital expenses are paid by public funds. In 2010, approximately 67% of hospitals were publicly owned. The share of private hospitals increased steadily from 30% in 2005 to 33% in 2010. GlobalData, the industry analysis specialist, has released its new report, “Healthcare, Regulatory and Reimbursement Landscape - Brazil”. The report is an essential source of information and analysis on Brazil’s healthcare, regulatory and reimbursement landscape, and identifies the key trends in the healthcare market. The report also provides insights into the country’s demographic, regulatory, and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. The report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData’s team of industry experts. For further details, please click or add the below link to your browser: http://www.globaldata.com/ Visit our report store: http://www.globaldata.com/ For more details contact: pressreleases@ North America: +1 646 395 5477 Europe: Asia Pacific: # # # GlobalData is a global market intelligence services company providing information research and analysis products and services. End
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number